When to initiate treatment is as important as what to use for the treatment of patients newly diagnosed with Waldenstrom macroglobulinemia (WM), a leading expert in the disease emphasizes.
“We have...
A possible new treatment option for transthyretin amyloidosis has shown promising results in an initial clinical trial.
Transthyretin amyloidosis (ATTR amyloidosis) is a rare, progressive, and fatal disease...
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok